Status:
UNKNOWN
Effect of Acceptance and Commitment Therapy on Psychotic Severity
Lead Sponsor:
Port Said University
Conditions:
Psychosis
Emotion Regulation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our study aims to assess the efficacy of Acceptance and Commitment Therapy on psychotic severity among Inpatients with primary psychosis: A Randomized Controlled Trial.
Detailed Description
Current study was an open label, two-arm, parallel, randomized controlled trial, evaluating the efficiency of Acceptance and Commitment Therapy (ACT) added to treatment as usual (TAU) as opposed to tr...
Eligibility Criteria
Inclusion
- Inclusion criteria Participants' criteria of inclusion involved those patients who were
- Current psychiatric hospitalization;
- DSM-5 diagnosis of a primary psychotic disorder; (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder, brief psychotic disorder, and unspecified psychotic disorder, this diagnosis was confirmed by a psychiatrist
- 18 years or older;
- ability to talk, read and write in Arabic; and
- willingness to participate in the study that was scheduled for seven weeks.
- Exclusion criteria Patients were excluded if they
- had a comorbid learning disability or organic brain disorder;
- psychosis related to a general medical condition or substance-induced psychotic disorder;
- were considered mentally unstable; or
- unfit to participate in the study by their therapist, and/or had newly had (been receiving) psycho-education or somewhat designed psychosocial intervention.
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 20 2023
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06160869
Start Date
October 1 2023
End Date
December 20 2023
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Dakahlia Governorate, Egypt, 25711